These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 646576)

  • 21. [Effects of treatment with 1--alpha-hydroxyvitamin D3 in osteodystrophy in uremic patients undergoing periodical hemodialysis].
    Albertazzi A; Palmieri PF; Del Rosso G; Spisni C; Evangelista M
    Minerva Nefrol; 1980; 27(4):631-3. PubMed ID: 7254690
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of 1 alpha-hydroxycholecalciferol (1 alpha-OH-D3) and eel calcitonin derivative in experimental renal osteodystrophy].
    Minatoguchi T
    Nihon Jinzo Gakkai Shi; 1982 Oct; 24(10):1157-71. PubMed ID: 7161947
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment with 1-alpha hydroxy vitamin D3 of bone disease in hemodialysis. Therapeutic results and complications].
    García de Vinuesa S; Barril G; Luño J; Alles A; Jofré R; Pérez García R; Olivas E; López Gómez JM; Valderrábano F
    Rev Clin Esp; 1980 Dec; 159(5):317-22. PubMed ID: 7221095
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hydroxylated metabolites of vitamin D. Therapeutic use of calcitriol and dihydrotachysterol].
    Stĕpán J; Lachmanová J; Wilczek H; Straková M; Zichová M; Horn V; Tomásek R; Pacovský V
    Cas Lek Cesk; 1985 Dec; 124(50):1550-6. PubMed ID: 3841297
    [No Abstract]   [Full Text] [Related]  

  • 25. Improvement of early renal bone disease with alfacalcidol therapy.
    CMAJ; 1995 Nov; 153(10):1470, 1472. PubMed ID: 7585375
    [No Abstract]   [Full Text] [Related]  

  • 26. Impairment of renal function in patients on 1alpha-hydroxycholecalciferol.
    Lancet; 1978 Aug; 2(8086):427-8. PubMed ID: 79789
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of 1-alpha-hydroxyvitamin D 3 treatment of osteodystrophy in uremic patients treated with periodic hemodialysis].
    Palmieri P; Albertazzi A; Cappelli P; Di Paolo B
    G Clin Med; 1981 Jul; 62(7):443-60. PubMed ID: 7308629
    [No Abstract]   [Full Text] [Related]  

  • 28. [New viewpoints on the therapy and prevention of renal osteopathy].
    Kaiser W; Mampel E
    Z Gesamte Inn Med; 1977 Jun; 32(12):254-9. PubMed ID: 333796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of renal rickets with 1 alpha-dydroxy cholecalciferol].
    Beer SI; Vure E; Krispin C; Varon M; Taunus A; Cohen D; Mazor J
    Harefuah; 1978 Jan; 94(1):15-7. PubMed ID: 640496
    [No Abstract]   [Full Text] [Related]  

  • 30. History and organization of the Growth Failure in Children with Renal Diseases Study.
    Chan JC; McEnery PT; Brouhard BH; Chinchilli VM; Greifer I
    J Pediatr; 1990 Feb; 116(2):S3-7. PubMed ID: 2405133
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical picture, diagnosis and therapy of renal osteodystrophy].
    Bombor H
    Z Urol Nephrol; 1977 Aug; 70(8):603-7. PubMed ID: 335702
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of 1,25(OH)2D3 and 24,25(OH)2D3 in the long-term treatment of renal osteodystrophy.
    Muirhead N; Catto GR; Edward N; Fraser RA; O'Riordan JL; Papapoulos SE; Adami S
    Proc Eur Dial Transplant Assoc; 1980; 17():543-7. PubMed ID: 6972529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of 99mTc pyrophosphate bone scintigraphy for vitamin D trials in uraemia.
    Vanherweghem JL; Dhaene M; Tielemans C; Dratwa M; Verbanck P; Bergmann P; Schoutens A; Fuss M
    Proc Eur Dial Transplant Assoc; 1981; 18():648-51. PubMed ID: 6276883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 25-hydroxyvitamin D3 (calcifediol) therapy of juvenile renal osteodystrophy: beneficial effect on linear growth velocity.
    Langman CB; Mazur AT; Baron R; Norman ME
    J Pediatr; 1982 May; 100(5):815-20. PubMed ID: 7069549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of renal bone disease with 1-alpha hydroxycholecalciferol].
    Shasha SM; Vinaver J; Chaimovitz C; Mazor J; Better OS
    Harefuah; 1976 Jul; 91(1-2):16-7. PubMed ID: 964770
    [No Abstract]   [Full Text] [Related]  

  • 36. Protocol of the Growth Failure in Children with Renal Diseases Study.
    Chan JC; McEnery PT; Chinchilli VM; Boyle RM; Massie MD; Jennings SS; Kohaut EC; Dresner IG; Tejani A; Arbus GS
    J Pediatr; 1990 Feb; 116(2):S17-21. PubMed ID: 2405130
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dihydrotachysterol treatment in children with chronic renal failure].
    Sieniawska M; Tolloczko I
    Pol Tyg Lek; 1977 Jan; 32(5):181-4. PubMed ID: 834657
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of dihydrotachysterol on bone tissue in rats with experimental kidney failure].
    Iagodovskiĭ VS; Ermolenko VM; Spirichev VB; Blazheevich NV; Migunova NA
    Biull Eksp Biol Med; 1980 Nov; 90(11):611-3. PubMed ID: 7448398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of 1 alpha-hydroxyvitamin D3 in children with renal osteodystrophy associated with hemodialysis.
    Chan JC; Oldham SB; DeLuca HF
    J Pediatr; 1977 May; 90(5):820-4. PubMed ID: 853343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proceedings: The use of metabolically-active derivatives of vitamin D in rickets and osteomalacia due to renal glomerular failure.
    Smith R; Henderson RG; Russell RG
    J Bone Joint Surg Br; 1975 May; 57(2):247-8. PubMed ID: 1141297
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.